|
EGFL8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.280200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.455200E-01 |
| Normal-vs-Stage2 |
4.653800E-01 |
| Normal-vs-Stage3 |
9.698600E-01 |
| Normal-vs-Stage4 |
8.930000E-01 |
| Stage1-vs-Stage2 |
1.865640E-01 |
| Stage1-vs-Stage3 |
4.117000E-01 |
| Stage1-vs-Stage4 |
6.270000E-01 |
| Stage2-vs-Stage3 |
4.614800E-01 |
| Stage2-vs-Stage4 |
4.926200E-01 |
| Stage3-vs-Stage4 |
9.115200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.754600E-01 |
| Normal-vs-AfricanAmerican |
1.514630E-01 |
| Normal-vs-Asian |
2.554400E-02 |
| Caucasian-vs-AfricanAmerican |
6.560000E-02 |
| Caucasian-vs-Asian |
3.924100E-02 |
| AfricanAmerican-vs-Asian |
3.856800E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.412200E-02 |
| Normal-vs-Female |
8.826800E-01 |
| Male-vs-Female |
2.742200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.729590E-01 |
| Normal-vs-Age(41-60Yrs) |
8.662400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.722400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.659600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.766650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.345900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.394600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.291800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.263000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.443400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.068010E-02 |
| Classical-VS-Follicular |
1.002420E-01 |
| Classical-VS-Other |
2.445200E-01 |
| Classical-VS-Normal |
2.565200E-01 |
| Tall-VS-Follicular |
3.065000E-01 |
| Tall-VS-Other |
1.320040E-01 |
| Tall-VS-Normal |
1.004960E-01 |
| Follicular-VS-Other |
8.387900E-02 |
| Follicular-VS-Normal |
5.448800E-01 |
| Other-VS-Normal |
2.761800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.911400E-01 |
| Normal-vs-N1 |
2.399600E-02 |
| N0-vs-N1 |
2.842000E-02 |
|
|
